# Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors

> **NCT04315883** · — · TERMINATED · sponsor: **Nemours Children's Clinic** · enrollment: 3 (actual)

## Conditions studied

- Hepatoblastoma
- Hepatocellular Carcinoma
- Rhabdoid Tumor of Liver
- Undifferentiated (Embryonal) Sarcoma of the Liver
- Pediatric Liver Cancer
- Liver Tumors

## Interventions

- **BEHAVIORAL:** Quality of Life Assessment
- **RADIATION:** Transarterial Radioembolization

## Key facts

- **NCT ID:** NCT04315883
- **Lead sponsor:** Nemours Children's Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2021-02-11
- **Primary completion:** 2024-03-28
- **Final completion:** 2024-03-28
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** PI left organization and discontinued study
- **Last updated:** 2024-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04315883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04315883, "Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04315883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*